Filter posts

JAMA Study Misses the Mark on Cancer R&D Costs & Profitability

Yesterday, JAMA Internal Medicine published a new paper purporting to estimate the R&D expense associated …

BIO Releases Points to Consider on Truthful and Non-Misleading Product Communication

Today, BIO releases Points to Consider on Truthful and Non-Misleading Product Communication. This document advances the dialogue …

8 Reasons New Medicines are Needed for Alzheimer’s

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel …

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About 'Big Pharma'

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big …

AIR 340B: New Analysis Shows Most 340B Hospitals Provide Little Charity Care

Today, the Alliance for Integrity and Reform of 340B (AIR 340B) released a new report, …